Manufacturer
(a) |
Sales
($ millions) (a) |
Active
Ingredients (b) |
Percent
of
Manufacturer's
Sales (b) |
Sales
($ millions)
(calculated) |
Active
Ingredients (c) |
Sales
($ millions) (c) |
| Ortho |
1.5 |
Rotenone |
10.0% |
0.15 |
Rotenone |
0.15 |
Pyrethroids and
pyrethrins |
90.0% |
1.35 |
Pyrethrins |
0.50 |
| Allethrin |
0.21 |
| Resmethrin |
0.21 |
| Tetramethrin |
0.21 |
| Other |
0.22 |
| Dexol |
1.5 |
Nicotine |
50.0% |
0.75 |
Nicotine |
0.75 |
| Methoprene |
50.0% |
0.75 |
Methoprene |
0.75 |
| Other |
2.0 |
Pyrethroids |
37.5% |
0.75 |
Allethrin |
0.25 |
| Resmethrin |
0.25 |
| Tetramethrin |
0.25 |
| Pyrethrins |
37.5% |
0.75 |
Pyrethrins |
0.75 |
| Dysiston |
12.5% |
0.25 |
Dysiston |
0.25 |
| Orthene (acephate) |
12.5% |
0.25 |
Acephate |
0.25 |
| Total |
5.0 |
|
|
5.0 |
|
|
|
Active
Ingredient (d) |
Sales
($ millions) (e) |
Probability
(calculated) (f) |
Probability
(adjusted) (g) |
| Pyrethrins |
1.25 |
25% |
38% |
| Nicotine |
0.75 |
15% |
15% |
| Methoprene |
0.75 |
15% |
15% |
| Allethrin |
0.46 |
9% |
14% |
| Tetramethrin |
0.46 |
9% |
14% |
| Resmethrin |
0.46 |
9% |
14% |
| Acephate |
0.25 |
5% |
8% |
| Dysiston |
0.25 |
5% |
5% |
| Rotenone |
0.15 |
3% |
3% |
| Other |
0.22 |
4% |
9% |
|
- Kline (Anonymous, 1982)
- Based on descriptive information in Kline (Anonymous, 1982) plus judgment.
- Sales for each active ingredient were assigned based on information in the Kline report (Anonymous, 1982) and judgment.
- Eliminating duplicates.
- Combining active ingredient sales across all manufacturers that produce it.
- Sales of each active ingredient divided by total sales ($5 million).
- Probabilities for pyrethrins, allethrin, tetramethrin, and "other" active ingredients were adjusted up to reflect their presence in multiple products.
|